Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Genesys International Corporation Limited (NSE: GENESYS), ISIN INE727B01026 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GENESYS last traded at ₹190.30 (+3.05%), with a 52-week range of ₹135.41 to ₹349.83 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 32.73%, FIIs 1.68%, DIIs 0.81%, mutual funds 0.00%.
EquiSense Score (ECS): 66/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.